AdAlta CEO Sam Cobb attended the Gold Coast Investment Showcase held on June 21-22, 2018. The showcase provides the opportunity for prospective investors to get up close and personal with some of the most exciting and innovative companies in Australia. This included biotechnology companies such as AdAlta, along with companies from the resources and technology sectors.
A recording of the presentation from the Gold Coast Investment Showcase can be viewed below, in which CEO Sam Cobb provides an overview of AdAlta including lead candidate, AD-214, which is being advanced for idiopathic pulmonary fibrosis, an indication with early transaction potential.
The significant achievements for AdAlta in 2017/18 along with expected news flow for the year ahead are also detailed in the presentation and our recent Shareholder Update.
If you would like to keep up on date on AdAlta’s progress, become a subscriber here.